The association between polymorphisms in glutathione S-transferase (GSTM1 and GSTT1) and lung cancer outcome

Cancer Investigation

Volumn 24, Issue 5, 2006, Pages 497-501

  Gonlugur, Ugur ^a,c   Pinarbasi, Hatice ^a   Gonlugur, Tanseli Efeoglu ^b   Silig, Yavuz ^a  

^a CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Sivas Devlet Hastanesi   (Turkey)

^c CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Chemotherapy; Glutathione; Metabolism

Indexed keywords

CISPLATIN; ETOPOSIDE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; COUGHING; DNA POLYMORPHISM; DYSPNEA; FEMALE; GENE; GENOTYPE; GSTM1 GENE; GSTT1 GENE; HEMOPTYSIS; HUMAN; LIVER METASTASIS; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUTROPENIA; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; THORAX PAIN; TUMOR VOLUME; WEIGHT REDUCTION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33750089792     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900600814813     Document Type: Article

References (28)

1. Pinarbasi, H.; Silig, Y.; Cetinkaya, O.; Seyfikli, Z.; Pinarbasi, E. Strong association between the GSTM1-null genotype and lung cancer in a Turkish population. Cancer Genetic Cytogenet. 2003, 146, 125-129.
2. Benhamou, S.; Lee, W.J.; Alexandrie, A.K.; Boffetta, P.; Bouchardy, C.; et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis. 2002, 23, 1343-1350.
3. Houlston, R.S. Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. Cancer Epidemiol. Biomark. Prev. 1999, 8, 675-682.
4. Hayes, J.D.; Pulford, D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 1995, 30, 445-460.
5. Mc Williams, J.E.; Sanderson, B.J.; Harris, E.L.; Richert-Boe K.E., Henner, W.D. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer. Epidemiol. Biomark. Prev. 1995, 4, 589-594.
6. Pinarbasi, H.; Silig, Y.; Gurelik, M. Genetic polymorphisms of GSTs and their association with primary brain tumor incidence. Cancer Genetic. Cytogenet. 2005, 156, 144-149.
7. London, S.J.; Yuan, J.M.; Chung, F.L.; Gao, Y.T.; Coetzee, G.A.; Ross, R.K.; Yu, M.C. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung cancer risk: a prospective study of men in Shanghai, China. Lancet 2000, 356, 724-729.
8. Shen, H.; Kauvar, L.; Tew, K.D. Importance of glutathione and associated enzymes in drug response. Oncol Res 1997, 9, 253-302.
9. Carmichael, J.; Mitchell, J.B.; Friedman, N.; Gazdar, A.F.; Russo, A. Glutathione and related enzyme activity in human lung cancer cell lines. Br. J. Cancer 1988 58, 437-440.
10. Gulick, A.M.; Fahl, W.E. Mammalian glutathione S-transferase: regulation of enzyme system to achieve chemotherapeutic efficacy. Pharmacol. Ther. 1995, 66, 237-257.
11. Goto, S.; Iida, T.; Cho, S.; Oka, M.; Kohno, S.; Kondo, T. Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells. Free. Radic. Res. 1999 31, 549-558.
12. World Health Organization. Histological typing of lung tumours. International classification of tumours. No. 1, second edition, Geneva, WHO, 1981.
13. Oken, M.M.; Creech, R.H.; Tormey, D.C.; Horton, J.; Davis, T.E.; McFadden, E.T.; Carbone, P.P. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am. J. Clin. Oncol. 1982, 5, 649-655.
14. Miller, S.A.; Dykes, D.D.; Polesky, H.F. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic. Acids. Res. 1988, 16, 1215.
15. Ge, H.; Lam, W.K.; Lee, J.; Wong, M.P.; Yew, W.W.; Lung, M.L. Analysis of L-myc and GSTM1 genotypes in Chinese non-small cell lung carcinoma patients. Lung. Cancer. 1996, 15, 355-366.
16. Przygodzki, R.M.; Bennett, W.P.; Guinee, D.G. jr.; Khan, M.A.; Freedman, A.; Shields, P.G.; Travis, W.D.; Jett, J.R.; Tazelar, H.; Pairolero, P.; Trastek, V.; Liotta, L.A.; Harris, C.C. Caporaso NE. p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer. Pharmacogenetics. 1998, 8, 503-511.
17. Yang, P.; Yokomizo, A.; Tazelaar, H.D.; Marks, R.S.; Lesnick, T.G.; Miller, D.L.; Sloan, J.A.; Edell, E.S.; Meyer, R.L.; Jett, J.; Liu, W. Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes. Lung. Cancer. 2002, 35, 221-229.
18. Sweeney, C.; Nazar-Stewart, V.; Stapleton, P.L.; Eaton, D.L.; Vaughan, T.L. Glutathione S-transferas M1, T1, and P1 polymorphisms and survival among lung cancer patients. Cancer. Epidemiol. Biomark. Prev. 2003, 12, 527-533.
19. Goto, I.; Yoneda, S.; Yamamoto, M.; Kawajiri, K. Prognostic significance of germ-line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer. Cancer. Res. 1996, 56, 3725-3370.
20. Yellin, S.A.; Davidson, B.J.; Pinto, J.T.; Sacks, P.G.; Qiao, C.; Schantz, S.P. Relationship of glutathione and glutathione-S-transferase to cisplatin sensitivity in human head and neck squamous carcinoma cell lines. Cancer. Lett. 1994, 85, 223-232.
21. Sark, M.V.; Timmer-Bosscha, H.; Meijer, C.; Uges, D.R.; Sluiter, W.J.; Peters, W.H.; Mulder, N.H.; de Vries E.G. Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines. Br. J. Cancer. 1995, 71, 684-690.
22. Nakanishi, Y.; Matsuki, H.; Takayama, K.; Yatsunami, J.; Kawasaki, M.; Abe, M.; Hara, N. Glutathione derivatives enhance adriamycin cytotoxicity in a human lung adenocarcinoma cell line. Anticancer. Res. 1997, 17, 2129-2134.
23. Chen, G.; Waxman, D.J. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells. Biochem. Pharmacol. 1994, 47, 1079-1087.
24. Davies, S.M.; Robison, L.L.; Buckley, J.D.; Tjoa, T.; Woods, W.G.; Radloff, G.A.; Ross, J.A.; Perentesis, J.P. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid lekemia. J. Clin. Oncol. 2001, 19, 1279-1287.
25. Cheng, S.L.; Yu, C.J.; Chen, C.J.; Yang, P.C. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur. Respir. J. 2004, 23, 818-824.
26. Yim, J.J.; Park, G.Y.; Lee, C.T.; Kim, Y.W.; Han, S.K.; Shim, Y.S.; Yoo, C.G. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax. 2000 55, 121-125
27. Gilliland, F.D.; Li, Y.F.; Saxon, A.; Diaz-Sanchez, D. Effect of glutathione-S-transferase M1 and P1 genotypes on xenobiotic enhancement of allergic responses: randomised, placebo-controlled crossover study. Lancet. 2004, 363, 119-125.
28. Gonlugur, U.; Akkurt, I.; Efeoglu, T. Classification of fibreoptic bronchoscopic findings: analysis of 2,698 cases. Comparative. Clinical Pathology 2004, 13, 1-3.